America's Car Mart (CRMT) Says Company-Specific Issues and Increased Competition Impacted 2Q Results; Jefferies Cuts Price Target to $29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Trump says Canada's Bombardier must build jets in US or lose market access
- Wall St slips as Gulf tensions send oil to over six-week high
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Unusual 11 Mid-Day Movers 11/20: (KBIO) (MCUR) (SRPT) Higher; (NMBL) (APTO) (MENT) Lower
November 20, 2015 12:46 PM ESTKaloBios Pharma (Nasdaq: KBIO) 81.3% HIGHER; announced that an investor group led by Martin Shkreli, the Founder and Chief Executive Officer of Turing Pharmaceuticals AG, has acquired 70% of its outstanding shares. KaloBios also announced the appointment of Martin Shkreli to the position of Chief Executive Officer and his election as Chairman of the Board. In his new role, Mr. Shkreli will work with the company's senior management team to ensure the Company's continued operations. KaloBios further announced that David Moradi, Tony Chase and Marek Biestek have been elected to the... More
America's Car Mart (CRMT) Misses Q2 EPS. Revenue Expectations
November 19, 2015 8:25 PM ESTAmerica's Car Mart (NASDAQ: CRMT) reported Q2 EPS of $0.29, $0.41 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $133 million versus the consensus estimate of $151.77 million.
Retail unit sales decrease of 10% to 10,881 from 12,084 for the prior year quarter with... MoreAmerica's Car Mart (CRMT) Halted, News Pending
November 19, 2015 4:55 PM ESTAmerica's Car Mart (NASDAQ: CRMT) Halted, News Pending
... More